SC Quashes CBI & ED Cases Against Sterling Biotech After ₹5100 Crore Settlement

The Supreme Court quashed criminal cases against Sterling Biotech after the company agreed to repay ₹5100 crore owed to banks. Allegations included fraud and money laundering. The Court observed that complete financial restitution justified closure of proceedings while balancing the public interest. This ruling illustrates the interaction between criminal liability and financial settlements, signaling that in exceptional circumstances where restitution fully satisfies creditors, prosecution may be curtailed. It also highlights judicial pragmatism in resolving large-scale corporate financial disputes.